
Please try another search
CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally. It offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dihydroxyphylline, theobromine, pentoxifylline, doxofylline, and raw enzymes; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC NBP Pharmaceutical Co., Ltd.
Name | Age | Since | Title |
---|---|---|---|
Ling Zhang | - | 2023 | Non-Employee Supervisor |
Lei Cai | 45 | 2020 | Non-Independent Director |
Long Dai | 33 | 2023 | Secretary, CFO & Director |
Congzhi Di | 50 | 2023 | Independent Director |
Dibin Li | 67 | 2023 | Independent Director |
Jiyong Zhang | 49 | 2017 | Chairman of the Supervisory Board |
Feng Han | 53 | 2017 | Director |
Peng Yang | 54 | 2023 | Independent Director |
Bing Yuan | 53 | 2020 | Employee Supervisor |
Jianping Zhou | 65 | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review